• CDC42 Polarity Regulates Intestinal Stem Cell Fate via YAP-m

  2026-07-13

  Zhang et al. uncovered that CDC42-driven apical-basal polarity is essential for the balance between intestinal stem cells (ISCs) and transit amplifying (TA) cells, acting through a YAP-EGF-mTOR signaling axis independently of canonical Wnt pathways. This mechanistic insight reframes epithelial polarity as a decisive regulator of intestinal crypt homeostasis and offers new directions for gastrointestinal stem cell research.

• Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit

  2026-07-13

  The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit addresses the challenge of resolving proteins and peptides in the 1–10 kDa range, which are not efficiently separated by standard Tris-glycine SDS-PAGE systems. It is intended for research workflows requiring high-resolution analysis of small proteins and peptides and should not be used for diagnostic or clinical applications.

• Enhancing Gram-Negative Assays: Aztreonam (SKU A5931) in Foc

  2026-07-12

  This article provides an evidence-driven exploration of Aztreonam (SKU A5931) for researchers facing challenges in Gram-negative bacterial assays. Drawing on recent resistance surveillance and hands-on laboratory scenarios, it demonstrates how Aztreonam’s defined solubility, reproducibility, and metabolic insights optimize experimental reliability for biomedical scientists.

• Patient-Derived Gastric Cancer Assembloids Advance Drug Rese

  2026-07-10

  This study introduces a patient-specific gastric cancer assembloid model that integrates matched tumor organoids with stromal cell subpopulations, more faithfully recapitulating the tumor microenvironment than traditional organoid cultures. The approach enhances the physiological relevance of preclinical drug sensitivity testing, providing new insights into resistance mechanisms and personalized therapy optimization.

• Morphological Profiling Reveals HSPB7 Rescue in Titin Cardio

  2026-07-09

  This study introduces CARDIO, a high-content morphological profiling assay, to systematically investigate cardiomyocyte responses in genetic models of dilated cardiomyopathy. The work uncovers HSPB7 loss as a novel modulator capable of rescuing contractile function in titin-deficient heart cells, offering new insight for heart failure research.

• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor-S

  2026-07-09

  This study introduces a novel patient-derived gastric cancer assembloid model that integrates matched tumor organoids with stromal cell subpopulations, closely mimicking the complexity of primary tumors. The approach enhances the physiological relevance of preclinical drug testing and offers new insights into mechanisms of drug resistance and personalized therapy strategies.

• Recombinant Human Oncostatin M: Catalyzing Translational Pro

  2026-07-08

  This article explores the mechanistic and translational impact of Recombinant Human Oncostatin M (E.coli, Tag Free, Lyophilized), integrating recent advances in cytokine biology, assay optimization, and disease modeling. It delivers actionable guidance for researchers aiming to bridge mechanistic insight with clinical relevance, while situating APExBIO’s product within a competitive and rapidly evolving experimental landscape.

• Lactate Drives HMGB1 Lactylation and Exosomal Release in Sep

  2026-07-08

  This study uncovers a mechanism by which lactate promotes both lactylation and acetylation of HMGB1 in macrophages, leading to its exosomal release and increased endothelial permeability during polymicrobial sepsis. These findings reveal lactate-associated signaling as a potential therapeutic target and underscore the importance of preserving post-translational modifications in sepsis research.

• Ambroxol Targets Nav1.8, TRPV1, and TRPA1 in Neuropathic Pai

  2026-07-07

  This study delineates how ambroxol, beyond its known mucolytic role, modulates human Nav1.8 sodium channels and the TRPV1 and TRPA1 receptors in vitro, elucidating a mechanistic basis for its topical analgesic effects in neuropathic pain. The findings clarify the molecular targets and species-specific nuances relevant to sensory neuron modulation, providing a foundation for refining pain research and therapeutic strategies.

• Silymarin and Silybin A: Advanced Workflows for Liver Diseas

  2026-07-07

  Silybin A, the principal bioactive of Silymarin, delivers reproducible, high-purity solutions for liver disease, inflammation, and metabolic enzyme modulation studies. This article provides actionable protocols, troubleshooting tactics, and comparative insights to optimize antioxidant and hepatoprotective assays based on APExBIO’s Silybin A.

• Estradiol–Autophagy Axis: Multi-Organ Protection in Perimeno

  2026-07-06

  This study integrates human cohort data, network pharmacology, and mouse models to reveal how declining estradiol levels increase cardiometabolic and renal risk during perimenopause. By mechanistically linking estrogen receptor signaling and autophagy, the research provides pivotal insights for organ-protective strategies in aging women.

• ATRX Loss Sensitizes High-Grade Glioma to Selective PDGFR In

  2026-07-06

  The referenced study demonstrates that ATRX-deficient high-grade glioma cells are markedly more sensitive to receptor tyrosine kinase and PDGFR inhibitors, highlighting a potential biomarker-driven approach for targeted therapy. These findings suggest that ATRX status should be considered in clinical trial design and therapeutic strategies for glioma.

• Blue Light Damages Skin Barrier via EGFR/ERK/c-Jun Pathway

  2026-07-05

  This study provides the first systematic evidence that blue light (BL) irradiation compromises skin barrier function in humans and mice by activating the EGFR/ERK/c-Jun signaling cascade. The findings highlight the molecular mechanisms of BL-induced epidermal thickening and dysfunction, opening new avenues for research on skin photoprotection and targeted intervention.

• BMS-777607: Strategic Advances in MET Pathway Inhibition

  2026-07-04

  This thought-leadership article explores how BMS-777607, a selective and orally available ATP-competitive c-Met inhibitor, is reshaping translational research in oncology and regenerative medicine. It examines mechanistic underpinnings, protocol optimization, and strategic considerations for researchers seeking robust, reproducible results in cancer metastasis and stem cell-derived platelet production, referencing the latest advances and practical guidance.

• Tunicamycin in HSC Mobilization: Beyond ER Stress Induction

  2026-07-03

  Explore Tunicamycin as a N-glycosylation inhibitor uniquely influencing endoplasmic reticulum stress, with new insights into hematopoietic stem cell mobilization. This article offers a deeper analysis than standard protocols, highlighting translational research value.

16034 records 1/1069 page Next 12345 下5页 Last page